Clinical trial
Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers Treated With Dihydroartemisinin-piperaquine in The Gambia
NCT01838902 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers Treated With Dihydroartemisinin-piperaquine in The Gambia
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- October 31, 2015
- Enrollment
- 467 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.